Ovarian Stimulation Clinical Trials

30 clinical trials for Ovarian Stimulation across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation — RECRUITING
• Follicular Volume at the Time of Final Oocyte Maturation in Poor Responders, and Its Correlation With Oocyte Maturity — RECRUITING
• AI-TOP Study Artificial Intelligence for Trigger Optimization. — RECRUITING · NA
• PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study — RECRUITING · PHASE4
• Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status? — RECRUITING
• Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA. — COMPLETED · PHASE1
• Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin — COMPLETED
• Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA — COMPLETED · PHASE1
• Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF) — NOT_YET_RECRUITING · PHASE4
• Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle — COMPLETED · NA
• The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger — OTHER · NA
• FSH AND LH VERSUS FSH ALONE FOR OVARIAN STIMULATION IN NON-HORMONE SENSITIVE ONCO-FERTILITY PATIENTS: A RANDOMIZED CONTROLLED TRIAL — NOT_YET_RECRUITING
• DOES SUBCUTANEOUS GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) IMPROVE OVARIAN RESERVE IN WOMEN WITH PREMATURE OVARIAN INSUFFICIENCY? — NOT_YET_RECRUITING
• The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response — COMPLETED · NA
• Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor — COMPLETED · PHASE4
• Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo — OTHER · PHASE2
• Efficacy and Safety of Medication Used to Stimulate Ovulation — OTHER · PHASE4
• Lutropin Alfa in Women at Risk of Poor Response — COMPLETED · PHASE2
• Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response — OTHER · PHASE4
• Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve — OTHER · NA
• Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles — TERMINATED · PHASE4
• Antagonist/Letrozole in Poor Responders — COMPLETED · PHASE1
• "A RANDOMISED, CONTROLLED, ASSESSOR-BLIND, PARALLEL GROUPS, MULTICENTRE, MULTINATIONAL TRIAL COMPARING THE EFFICACY AND SAFETY OF FE 999049 WITH FOLLITROPIN ALFA (GONAL-F) IN CONTROLLED OVARIAN STIMULATION IN WOMEN UNDERGOING AN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMME. ESTHER-1 (EVIDENCE-BASED STIMULATION TRIAL WITH HUMAN RFSH IN EUROPE AND REST OF WORLD)." — COMPLETED
• "A CONTROLLED, ASSESSOR-BLIND, PARALLEL GROUPS, MULTICENTRE, MULTINATIONAL TRIAL EVALUATING THE IMMUNOGENICITY OF FE 999049 IN REPEATED CYCLES OF CONTROLLED OVARIAN STIMULATION IN WOMEN UNDERGOING AN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMME. ESTHER-2 (EVIDENCE-BASED STIMULATION TRIAL AND HUMAN RFSH IN EUROPE AND REST OF THE WORLD) — COMPLETED
• A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies — COMPLETED · PHASE3
• Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment — COMPLETED · NA
• Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles — COMPLETED · PHASE3
• Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist — COMPLETED · PHASE4
• Impact of Three Different Gonadotrophin Regimes on Egg Donation Program — COMPLETED · PHASE4
• Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles — COMPLETED · PHASE3

Refine this search